Samuraciclib hydrochloride
Product Specifications
CAS Number
1805789-54-1
Target
Apoptosis|||CDK
Related Pathways
Cell Cycle/Checkpoint|||Apoptosis
Purity
0.998
Bioactivity
Samuraciclib hydrochloride (ICEC0942 hydrochloride) is a potent, selective, ATP competitive and oral active CDK7 inhibitor with IC50 of 41 nM. The selectivity of Samuraciclib hydrochloride is 45-, 15-, 230- and 30-fold higher than CDK1, CDK2 (IC50 is 578 nM), CDK5 and CDK9 respectively. Samuraciclib hydrochloride inhibits the growth of breast cancer cell lines with GI50 values between 0.2-0.3 ?M. Samuraciclib hydrochloride has anti-tumor effects.
Smiles
Cl.CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12
Molecular Formula
C22H31ClN6O
Molecular Weight
430.97
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1229472-01 0.02 mg (E-Coli)
Recombinant Danio rerio CTD small phosphatase-like protein 2-B (ctdspl2b)
Ask
View Details